Toxoplasma IgG/IgM Rapid Test Device (WB/S/P)

The Toxoplasma IgG/IgM Rapid Test Device is an antibody-based rapid screening test used to detect immune response against Toxoplasma gondii. IgM antibodies may suggest recent infection, while IgG antibodies may indicate previous exposure or later immune response.

• Toxoplasmosis is an infection caused by the parasite Toxoplasma gondii.
• The infection may occur through undercooked contaminated meat, contaminated food or water, exposure to infected cat feces, or congenital transmission during pregnancy.
• Most healthy individuals may have mild or no symptoms, but toxoplasmosis can be important in pregnancy and immunocompromised patients.
• Rapid antibody screening may support prenatal care programs, infectious disease evaluation, and professional laboratory workflows.

The Toxoplasma IgG/IgM Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and infectious disease screening environments.

Applications

• Hospitals and clinics
• Diagnostic laboratories
• Prenatal care programs
• Pregnancy screening workflows
• Infectious disease screening settings
• Professional point-of-care testing
• Healthcare screening programs
• Medical procurement agencies
• International diagnostic distribution

• The Toxoplasma IgG/IgM Rapid Test Device works on lateral flow immunochromatographic assay technology.
• When the specimen is applied to the sample area, it migrates across the membrane by capillary action.
• If Toxoplasma gondii IgG or IgM antibodies are present, they react with coated antigens and create visible test lines.
• The test generally includes IgG line, IgM line, and control line for valid test performance.

The Toxoplasma IgG/IgM Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection of Toxoplasma gondii IgG and IgM antibodies in whole blood, serum, or plasma specimens.

Benefits

• Detects Toxoplasma gondii IgG antibodies
• Detects Toxoplasma gondii IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Supports prenatal and infectious disease screening
• Useful for professional point-of-care testing

The Toxoplasma IgG/IgM Rapid Test Device supports whole blood, serum, and plasma specimens. This flexibility makes the test practical for different laboratory and clinical workflows.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Apply the specimen correctly to the sample area
• Add buffer according to instructions
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Toxoplasma IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection of Toxoplasma gondii IgG and IgM antibodies in whole blood, serum, or plasma specimens.

• An IgM-positive result may suggest recent or active immune response to Toxoplasma gondii.
• An IgG-positive result may indicate previous exposure or past infection.
• Results should be interpreted with symptoms, pregnancy status, exposure history, and laboratory evaluation.
• Further laboratory testing may be recommended depending on clinical findings and healthcare guidelines.

The Toxoplasma IgG/IgM Rapid Test Device is intended as a professional screening aid and should not be used as the only basis for diagnosis or treatment decisions.

Instructions

• For professional in-vitro diagnostic use only
• Use approved whole blood, serum, or plasma specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• Antibody detection alone should not replace clinical evaluation
• Further laboratory testing may be required
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects Toxoplasma gondii IgG antibodies
• Detects Toxoplasma gondii IgM antibodies
• Suitable for whole blood, serum, and plasma
• Rapid visual result
• Simple professional testing workflow
• No complex instrument required
• Supports prenatal and infectious disease screening
• Suitable for international diagnostic supply

Note

The Toxoplasma IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed for fast, practical, and accessible toxoplasmosis antibody screening support.

Steps

• Bring the test device, specimen, and buffer to room temperature
• Open the sealed pouch only when ready to test
• Place the device on a clean flat surface
• Add whole blood, serum, or plasma to the sample area
• Add buffer according to the product insert
• Wait for the recommended reaction time
• Read the IgG, IgM, and control lines within the valid time window
• Do not interpret results after the recommended reading time
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

An IgM-positive result may suggest recent immune response to Toxoplasma gondii, while an IgG-positive result may indicate previous exposure or past infection.

Negative

A negative result means Toxoplasma gondii IgG/IgM antibodies were not detected at the test’s detectable level.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device.

Instructions

• Store the Toxoplasma IgG/IgM Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test device
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with clinical findings and patient history

LARKSOIS Pharma provides globally suitable diagnostic products for hospitals, clinics, laboratories, healthcare distributors, and public health programs. The Toxoplasma IgG/IgM Rapid Test Device (WB/S/P) is designed for fast, practical, and accessible toxoplasmosis antibody screening support.

Advantages

• International infectious disease rapid test portfolio
• Reliable toxoplasmosis antibody screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible prenatal screening solution